It is therefore likely that, like for the additional alterations such as trisomy 8 and isochromosome 17q, the observed EVI1 overexpression contributes to the aggressive phenotype of the blastic CML phase. Here, MECOM is linked to chronic myelogenous leukemia, BCR-ABL1 positive.